Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
International Journal of Medical Informatics|August 24, 2022
Patients' use of smartphone apps for health record access in 2019: A cross-sectional studyOliver T Nguyen, Chelsea P Renfro, Jonathan Hughes, et al.Journal of the American Medical Informatics Association : JAMIA|December 13, 2021
Primary care physicians' electronic health record proficiency and efficiency behaviors and time interacting with electronic health records: a quantile regression analysisOliver T Nguyen, Kea Turner, Nate C Apathy, et al.Journal of Biomedical Semantics|June 7, 2024
Multi-task transfer learning for the prediction of entity modifiers in clinical text: application to opioid use disorder case detectionAbdullateef I Almudaifer, Whitney Covington, JaMor Hairston, et al.International Journal of Cancer|February 11, 2020
End of an era for erythropoiesis-stimulating agents in oncologyMartin W Schoen, Shamia Hoque, Bartlett J Witherspoon, et al.Journal of Oncology Practice|May 16, 2017
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced AnemiaVirginia Noxon, Kevin B Knopf, LeAnn B Norris, et al.The Lancet. Oncology|December 3, 2020
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse ReactionsCharles L Bennett, Martin W Schoen, Shamia Hoque, et al.Plos One|June 26, 2020
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemiaShamia Hoque, Brian J Chen, Martin W Schoen, et al.Plos One|August 1, 2019
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactionsCharles L Bennett, Benjamin Schooley, Matthew A Taylor, et al.Eclinicalmedicine|February 8, 2021
Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)Charles L Bennett, Shamia Hoque, Nancy Olivieri, et al.Pageof 8